Correction to: Thalidomide maintenance therapy in Japanese myeloma patients: a multicenter, phase II clinical trial (COMET study) (International Journal of Hematology, (2019), 109, 4, (409-417), 10.1007/s12185-019-02607-z)

Hirokazu Murakami; Tetsuhiro Kasamatsu; Jun Murakami; Toru Kiguchi; Takeshi Kanematsu; Daisuke Ogawa; Hiroyuki Takamatsu; Hiroshi Handa; Shuji Ozaki; Hirokazu Miki; Takeshi Takahashi; Takaaki Takeo; Tatsuya Yamauchi; Takanobu Morishita; Hiroshi Kosugi; Kazuyuki Shimizu

doi:10.1007/s12185-019-02663-5

Correction to: Thalidomide maintenance therapy in Japanese myeloma patients: a multicenter, phase II clinical trial (COMET study) (International Journal of Hematology, (2019), 109, 4, (409-417), 10.1007/s12185-019-02607-z)

Hirokazu Murakami
, Tetsuhiro Kasamatsu
, Jun Murakami
, Toru Kiguchi
, Takeshi Kanematsu
, Daisuke Ogawa
, Hiroyuki Takamatsu
, Hiroshi Handa
, Shuji Ozaki
, Hirokazu Miki
, Takeshi Takahashi
, Takaaki Takeo
, Tatsuya Yamauchi
, Takanobu Morishita
, Hiroshi Kosugi
, Kazuyuki Shimizu

研究成果: ジャーナルへの寄稿 › コメント/討論 › 査読

抄録

The authors would like to correct the errors in the publication of the original article. The correction details are given below.

本文言語	英語
ページ（範囲）	125-126
ページ数	2
ジャーナル	International Journal of Hematology
巻	110
号	1
DOI	https://doi.org/10.1007/s12185-019-02663-5
出版ステータス	出版済み - 01-07-2019
外部発表	はい

All Science Journal Classification (ASJC) codes

血液学

文献へのアクセス

10.1007/s12185-019-02663-5

他のファイルとリンク

フィンガープリント

「Correction to: Thalidomide maintenance therapy in Japanese myeloma patients: a multicenter, phase II clinical trial (COMET study) (International Journal of Hematology, (2019), 109, 4, (409-417), 10.1007/s12185-019-02607-z)」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル

Murakami, H., Kasamatsu, T., Murakami, J., Kiguchi, T., Kanematsu, T., Ogawa, D., Takamatsu, H., Handa, H., Ozaki, S., Miki, H., Takahashi, T., Takeo, T., Yamauchi, T., Morishita, T., Kosugi, H., & Shimizu, K. (2019). Correction to: Thalidomide maintenance therapy in Japanese myeloma patients: a multicenter, phase II clinical trial (COMET study) (International Journal of Hematology, (2019), 109, 4, (409-417), 10.1007/s12185-019-02607-z). International Journal of Hematology, 110(1), 125-126. https://doi.org/10.1007/s12185-019-02663-5

Murakami, Hirokazu ; Kasamatsu, Tetsuhiro ; Murakami, Jun その他. / Correction to : Thalidomide maintenance therapy in Japanese myeloma patients: a multicenter, phase II clinical trial (COMET study) (International Journal of Hematology, (2019), 109, 4, (409-417), 10.1007/s12185-019-02607-z). In: International Journal of Hematology. 2019 ; Vol. 110, No. 1. pp. 125-126.

@article{292f107a9ec24c86a29045b9ef5f48c1,

title = "Correction to: Thalidomide maintenance therapy in Japanese myeloma patients: a multicenter, phase II clinical trial (COMET study) (International Journal of Hematology, (2019), 109, 4, (409-417), 10.1007/s12185-019-02607-z)",

abstract = "The authors would like to correct the errors in the publication of the original article. The correction details are given below.",

author = "Hirokazu Murakami and Tetsuhiro Kasamatsu and Jun Murakami and Toru Kiguchi and Takeshi Kanematsu and Daisuke Ogawa and Hiroyuki Takamatsu and Hiroshi Handa and Shuji Ozaki and Hirokazu Miki and Takeshi Takahashi and Takaaki Takeo and Tatsuya Yamauchi and Takanobu Morishita and Hiroshi Kosugi and Kazuyuki Shimizu",

note = "Publisher Copyright: {\textcopyright} 2019, Japanese Society of Hematology.",

year = "2019",

month = jul,

day = "1",

doi = "10.1007/s12185-019-02663-5",

language = "English",

volume = "110",

pages = "125--126",

journal = "International Journal of Hematology",

issn = "0925-5710",

publisher = "Springer",

number = "1",

}

Murakami, H, Kasamatsu, T, Murakami, J, Kiguchi, T, Kanematsu, T, Ogawa, D, Takamatsu, H, Handa, H, Ozaki, S, Miki, H, Takahashi, T, Takeo, T, Yamauchi, T, Morishita, T, Kosugi, H & Shimizu, K 2019, 'Correction to: Thalidomide maintenance therapy in Japanese myeloma patients: a multicenter, phase II clinical trial (COMET study) (International Journal of Hematology, (2019), 109, 4, (409-417), 10.1007/s12185-019-02607-z)', International Journal of Hematology, vol. 110, no. 1, pp. 125-126. https://doi.org/10.1007/s12185-019-02663-5

Correction to: Thalidomide maintenance therapy in Japanese myeloma patients: a multicenter, phase II clinical trial (COMET study) (International Journal of Hematology, (2019), 109, 4, (409-417), 10.1007/s12185-019-02607-z). / Murakami, Hirokazu; Kasamatsu, Tetsuhiro; Murakami, Jun その他.
In: International Journal of Hematology, Vol. 110, No. 1, 01.07.2019, p. 125-126.

研究成果: ジャーナルへの寄稿 › コメント/討論 › 査読

TY - JOUR

T1 - Correction to

T2 - Thalidomide maintenance therapy in Japanese myeloma patients: a multicenter, phase II clinical trial (COMET study) (International Journal of Hematology, (2019), 109, 4, (409-417), 10.1007/s12185-019-02607-z)

AU - Murakami, Hirokazu

AU - Kasamatsu, Tetsuhiro

AU - Murakami, Jun

AU - Kiguchi, Toru

AU - Kanematsu, Takeshi

AU - Ogawa, Daisuke

AU - Takamatsu, Hiroyuki

AU - Handa, Hiroshi

AU - Ozaki, Shuji

AU - Miki, Hirokazu

AU - Takahashi, Takeshi

AU - Takeo, Takaaki

AU - Yamauchi, Tatsuya

AU - Morishita, Takanobu

AU - Kosugi, Hiroshi

AU - Shimizu, Kazuyuki

PY - 2019/7/1

Y1 - 2019/7/1

N2 - The authors would like to correct the errors in the publication of the original article. The correction details are given below.

AB - The authors would like to correct the errors in the publication of the original article. The correction details are given below.

UR - https://www.scopus.com/pages/publications/85066898762

UR - https://www.scopus.com/pages/publications/85066898762#tab=citedBy

U2 - 10.1007/s12185-019-02663-5

DO - 10.1007/s12185-019-02663-5

M3 - Comment/debate

C2 - 31119612

AN - SCOPUS:85066898762

SN - 0925-5710

VL - 110

SP - 125

EP - 126

JO - International Journal of Hematology

JF - International Journal of Hematology

IS - 1

ER -

Murakami H, Kasamatsu T, Murakami J, Kiguchi T, Kanematsu T, Ogawa D その他. Correction to: Thalidomide maintenance therapy in Japanese myeloma patients: a multicenter, phase II clinical trial (COMET study) (International Journal of Hematology, (2019), 109, 4, (409-417), 10.1007/s12185-019-02607-z). International Journal of Hematology. 2019 7月 1;110(1):125-126. doi: 10.1007/s12185-019-02663-5